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Abstract
Background: Angina pectoris causes substantial psychological and functional disabilities and adversely effects
quality of life in patients. The aim of this study was to investigate the psychometric properties including validity and
reliability of the Farsi version of the Seattle angina questionnaire.
Methods: The ‘forward-backward’ procedure was applied to translate this questionnaire from English to Farsi. The
translated version of the Seattle angina questionnaire was assessed in terms of validity and reliability with a
convenience sample of 200 patients suffering from angina pectoris who were recruited from the inpatient ward (post
CCU) and outpatient department at two teaching hospitals in an urban area of Iran. Validity was assessed using
content, face and construct validity. The calculation of the Cronbach’s alpha coefficient and the test-retest method
helped with the assessment of reliability of the questionnaire’s five subscales. Construct validity of the questionnaire
was evaluated using exploratory factor analysis.
Results: The results of exploratory factor analysis indicated a five-factor solution for the questionnaire including ‘physical
limitation in middle to strenuous activities’, ‘physical limitation in slight activities’, ‘angina pattern and discomfort
of treatment’, ‘treatment satisfaction’ and ‘disease perception’ that jointly accounted for 64.42% of variance observed.
Convergent validity was mostly supported by the pattern of association between the Seattle angina
questionnaire-Farsi version and the SF-36. Cronbach’s alpha of the subscales ranged from 0.60 to 0.86 and test-retest
scores ranged from 0.79 to 0.97 indicating a good range of reliability.
Conclusions: The Seattle angina questionnaire-Farsi version had acceptable psychometric properties. Therefore, it can
be used to assess health-related quality of life and assess the effects of different medical and nursing interventions on
patients’ quality of life.
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Background
Cardiovascular disease (CVD) is the leading cause of
death and disability across the world [1, 2]. In Iran, a
Middle Eastern country, CVD is also the foremost cause
of death in adults aged 35 years and older [3]. Angina
pectoris is the most common type of CVD and accounts
for the majority of hospital admissions. Angina pectoris
is characterized by the feelings of chest pressure or pain
secondary to imbalance between myocardial oxygen
supply and demand caused by the coronary artery ob-
struction [4]. Patients with angina pectoris usually suffer
from fear, anxiety, and impaired ability to perform activ-
ities of daily livings [5]. Recurrent episodes of angina
also require repeated hospitalization in coronary care
units (CCU), which in turn impose stress on patients
and family members and heavy financial burdens on the
healthcare system [6]. Moreover, angina pectoris
threatens patients’ health-related quality of life (QoL).
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Consequently, monitoring QoL in patients with angina
pectoris is very important [7].
Health-related QoL is a state in which patients feel
emotionally, socially, and physically satisfied [8].
Patients’ perceptions of a certain medical or surgical
treatment are required for judging its success [9]. The
evaluation of healthcare outcomes is a fundamental pre-
requisite for assessing he success of treatment modal-
ities. Different general and disease-specific
questionnaires have been developed to evaluate health-
care outcomes such as the patient’s QoL. Disease-
specific questionnaires measure healthcare outcomes
that are related mainly to the course of the disease and
its progression in specific patient populations [7, 10, 11].
These questionnaires deal with the specific aspects
of diseases and provide higher response rates due to
their relevance for respondents. Moreover, disease-
specific questionnaires are more sensitive to health
alterations [12, 13].
The Seattle angina questionnaire (SAQ) as a disease-
specific questionnaire is developed for the evaluation of
health-related QoL in patients with angina pectoris [14].
SAQ has been used extensively in different studies [15–18].
Cultural adaptation and psychometric properties of the ori-
ginal and translated versions of the SAQ have been assessed
in different countries including but not limited to USA
[19], Japan [20], the UK [21], Norway [22], and Germany
[23]. These studies have confirmed that the SAQ is a valid
and reliable questionnaire for the measurement of QoL in
patients with angina pectoris living in different cultures and
contexts. The SAQ was translated into Farsi in a pilot study
and early version by Taheri Kharame et al. [24], but they
did not evaluate its advance pschomeric properties. There-
fore, this study was carried out to translate the SAQ and
assess the psychometric properties of the Farsi version of
SAQ (SAQ-F) as a disease-specific QoL scale in patients
with angina pectoris in Iran.
Methods
Participants and study setting
This methodological study was conducted in an urban
area in the centre of Iran from June 2014 to March
2015. As the samples of this study, 200 patients were re-
cruited from the inpatient ward (post CCU) and out-
patient clinics at two teaching hospitals. The patients
were selected using a convenient sampling method
according to the following inclusion criteria:
 age more than 20 years;
 being diagnosed with angina pectoris by a
cardiologist;
 the history of heart diseases for more than 6
months;
 ability to communicate in Farsi;
 having no previous psychiatric diseases;
 not taking any psychoactive drugs;
 willingness to participate in this study.
The study procedure was explained to those patients
who met the eligibility criteria. The questionnaire
was given to the patients and analysed by the principal
researcher (MHK). The questionnaire completion took
between 10 and 15 min.
Instruments
For data collection, a three-part questionnaire was used
as follows:
Socio-demographic form
To collect clinical and socio-demographic data of the
patients, a questionnaire consisting of questions about
age, the marital status, education level, employment,
economic status, smoking and medical history was
used.
SAQ
QoL was measured using the SAQ [14]. It was a disease-
specific instrument for patients with CVD. The SAQ-F
contained 19 items to quantify five clinically relevant do-
mains of CVD including physical limitations due to the
symptoms of angina, angina stability, angina frequency,
treatment satisfaction and disease perception. Scores ob-
tained in these domains were transformed and expressed
from 0 to 100, where higher scores indicated better qual-
ity of life. Since each domain monitored a unique di-
mension of CVD, no summation of scores was
generated.
SF-36
QoL was assessed using the SF-36 questionnaire as a
general health-related QoL instrument. The SF-36 had
eight subscales including physical functioning, bodily
pain, general health, vitality, social functioning, role limi-
tations due to physical problems, role limitations due to
emotional problems and mental health. Scores in each
scale ranged from 0 to 100, with zero representing the
worst QoL and 100 representing the best possible score.
It was reported that the original and Farsi versions of
this questionnaire had appropriate reliability and con-
struct validities [25, 26].
Translation procedure and evaluation of validity
After obtaining the permission from the author for the
translation and application of the SAQ, it was translated
as a part of the international quality of life assessment
project (IQoLAP) [25]. This approach to translation
and validation has been developed for use with the SF-
36, but it is also applicable to other translation efforts.
Taheri-Kharameh et al. Health and Quality of Life Outcomes  (2017) 15:234 Page 2 of 8
The questionnaire was translated from English to Farsi
by two doctoral nurses and the primary Farsi version of
the questionnaire was developed based on the compari-
son of the two translations. Next, the Farsi version was
back-translated to English by a translator who had no
previous knowledge of the SAQ. The original and back-
translated versions were compared item by item and a
final Farsi version of the questionnaire was reached.
After the completion of translation, a multidisciplinary
panel of healthcare professionals and academics was de-
veloped to test content validity of the questionnaire. The
panel included two cardiologists, six nursing profes-
sionals as faculty of members of two medical sciences
universities in Iran, and two clinical nurses with the ex-
perience of working in the cardiology ward. They were
asked to comment on the reasonability and suitability,
and logical sequence of items as well as comprehensive-
ness of the questionnaire. Moreover, to assess the ques-
tionnaire’s face validity, it was given to 10 patients with
angina pectoris to assess its comprehensibility and legi-
bility. According to the presented comments and per-
spectives by the experts and patients, some items were
modified. The instrument was anglicized by slight word-
ing changes of three items: (i), within the physical limita-
tions dimension the phrase of “walking more than one
block.. .” was changed to “walking more than 100 me-
tres.. .”, (ii), the phrase “past 4 weeks” was changed to
“past 1 month” within 3, 4 and 9 items, and (iii), the
word “bothersome” was changed to “worrisome” for one
of the items within the treatment satisfaction dimension.
For data collection, the study procedure was explained
to the patients who met the eligibility criteria. The ques-
tionnaire’s items were read for those patients who were
unable to read it and their answers were checked by the
principal researcher. The questionnaire completion took
between 10 and 15 min.
Two weeks after that the first survey, the SAQ-F was
disseminated again to 30 patients who had responded to
the first set of questionnaires and who had agreed to fill
in the SAQ-F administered twice-with a two-week inter-
val [27]. This procedure was conducted to check the
questionnaire reliability using the test-retest method.
Data analysis
Data analysis was conducted using SPSS v.16 software
for Windows. Patient characteristics and the score for
each domain of the SAQ-F were analysed by using
descriptive statistics. Construct validity of the question-
naire was performed using exploratory factor analysis.
Principle components analysis with varimax rotation was
applied. The Kaiser-Meyer-Olkin (KMO) and Bartlett’s
Test of Sphericity were used to assess the appropriate-
ness of the sample for factor analysis. Eigen values above
1 and the scree plot were used to determine the number
of factors. Factor loadings equal or greater than 0.4 were
considered appropriate [28]. As known group
comparison, the SAQ-F scores of patients with and
without chest symptoms were evaluated using the
Mann-Whitney U test. To assess the concurrent validity
of the SAQ-F, the Pearson’s correlation coefficient be-
tween the scores of the SAQ-F and SF-36 was computed.
Internal consistency of each scale of the SAQ-F was de-
termined using the calculation of the Cronbach’s
alpha coefficient. Cronbach’s α coefficient 0.7 or above
was considered to be satisfactory [29]. Test-retest reli-
ability was assessed by computing the intra-class correl-
ation coefficient of each domain. The time interval for
this assessment was 2 weeks in this study. An ICC > 0.80
indicated good test–retest reliability and stability [28].
Results
The demographic characteristics of the patients
Mean (standard deviation) of the patients’ age was
59.46 years (SD = 11.24). Also, 57.5% were females and
84.5% were married. Further information about the char-
acteristics of the participants were presented in Table 1.
Construct validity
Exploratory factor analysis
The Kaiser-Meyer-Olkin adequacy was 0.80 and
Bartlett’s test of sphericity was significant (p < 0.001), in-
dicating sample adequacy. Factor analysis with principal
component factor analysis and varimax rotation was
used to determine construct validity by excluding items
with factor loadings below 0.3. After varimax rotation, a
total of 19 items loaded significantly on five factors. All
five factors had an eigenvalue greater than 1, with an ex-
plained variance of 64.42%. Except one item, factor load-
ings ranged from 0.53 to 0.85. One item was deleted
(factor loading <0.3). The scree plot suggested generat-
ing a five-factor model (Fig. 1).
The first factor was related to physical limitation in
middle to strenuous activities (4, 5, 6, 7, 8, 9); The
second factor was physical limitation in slight activities
(1, 2, 3); The third factor was angina pattern and dis-
comfort of treatment (11, 12, 13); The fourth factor was
treatment satisfaction (14, 15, 16); The fifth factor was
disease perception (17, 18, 19). Further information
about the factor structure was reported in Table 2.
Discriminant validity
With regard to the known group comparison (Table 3),
the patients without chest symptoms exhibited signifi-
cantly higher SAQ-F scores than those who had poor
scores for the physical limitation in slight activities, an-
gina pattern and discomfort of treatment and disease
perception domains.
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Convergent validity
Table 4 showed the correlation between SAQ-F and SF-
36, which was used to assess convergent validity. SAQ-F
score demonstrated a significant and small-to-moderate
levels of correlation with the SF-36 score (r= 0.17– 0.69,
p < 0.01).
Reliability
Cronbach coefficients for the subscales ranged between
0.54 and 0.88. For the test–retest reliability, the ICC co-
efficients ranged between 0.79 and 0.97 (p < 0.001).
Table 5 showed internal consistency and test retest reli-
ability of the SAQ-F.
Discussion
The aim of this study was to assess the psychometric
properties of the SAQ-F with an Iranian population. Pre-
vious studies across cultures were conducted to assess
and promote QoL in patients with CVD[13]. Most of
these studies aimed to investigate the effects of nurs-
ing interventions on QoL in patients with CVD.
However, an absolute prerequisite of these studies is
the availability of a standard, valid and reliable
questionnaire.
In this study, the SAQ-F was translated based on the
instrument translation and cultural adaptation guidelines
[30]. The strengths of this study were the four steps of
instrument translation and ensuring the cultural adapta-
tion of the translated version. Face and the content val-
idities of the questionnaire were confirmed after
some minor revisions.
Moreover, the exploratory factor analysis was used to
evaluate construct validity of this questionnaire. The
KMO value was high and the Bartlett’s test was signifi-
cant indicating the appropriateness of the factor analysis
model. The scree plot showed that the SAQ-F was con-
sisted of five factors. These factors included ‘physical
limitation in middle to strenuous activities’, ‘physical
limitation in slight activities’, ‘angina pattern and discom-
fort of treatment’, ‘treatment satisfaction’ and ‘disease
perception’. However, this factor structure was not iden-
tical to the original structure [14]. Applying the SAQ-F
in different cultures potentially results in discrepancies
in the factor structure. The difference between the ori-
ginal and the SAQ-F was that the ‘anginal stability’ sub-
scale was deleted from the current Farsi version. Given
the fact that this subscale was consisted of only one
item, its deletion could be justifiable. Moreover, in the
Farsi version, the ‘physical limitation’ subscale of the ori-
ginal version was divided into two subscales including
‘physical limitation in middle to strenuous activities’
(consisting of six items) and ‘physical limitation in slight
activities’ (consisting of three items). Similarly, Kimble et
al. [31] reported the division of physical limitation
Table 1 The clinical and socio-demographic information of the
patients (N = 200)
Number Percent
Age (years)
Mean (SD) 59.46 11.24
Gender
Male 85 42.5
Female 115 57.5
Education level
Illiterate 81 40.5
Primary school 87 43.5
High school 25 12.5
Secondary school 7 3.5
Marital status
Single 2 1
Married 169 84.5
Divorced/widow 29 14.5
Employment status
Employed 60 30
Unemployed/housewife 140 70
Economic status
Poor 93 46.5
Good 107 53.5
Smoking status
Smoker 51 25.5
Non-smoker 149 74.5
Family history of CVD 81 40.5
Yes 88 92.63
No 7 3.37
Duration of heart disease, y
Mean (SD) 3.47 3.37
Medical history
Hypertension 103 51.5
Diabetes mellitus 78 39
Hypercholesterolaemia 95 47.5
Previous cardiac revascularizaton 48 24
Angina functional class
I 59 29.5
II 89 44.5
III 50 25
IV 2 1
Ejection fraction (%)
Mean (SD) 53 4.6
I: no limitation of ordinary physical activity
II: slight limitation of ordinary physical activity
III: marked limitation of ordinary physical activity
IV: unable to carry on any physical activity without discomfort
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subscale in two separate factors including ‘limitation in
activities with middle to high exertional requirements’
and ‘limitation in activities with low exertional require-
ments’ in women with chronic stable angina.
The factor structure of the SAQ-F as determined in
the current study was consisted of five factors. As previ-
ously indicated, while they were not identical to the ori-
ginal version, the SAQ-F also reported a five-factor
structure [14]. In comparison, Garratt et al. [21] evalu-
ated the psychometric characteristics of the British ver-
sion of the SAQ and reported a structure consisting of
three factors including treatment satisfaction, angina fre-
quency and perception and physical limitations. Kimble
[31] also evaluated the psychometric properties of the
SAQ in a sample of 175 women with chronic stable an-
gina and reported a six-factor structure.
In this study, a known-groups comparison method to
evaluate the discriminant validity of the SAQ-F was con-
ducted. Accordingly, the questionnaire was administered
to a sample of symptomatic and asymptomatic patients.
Fig. 1 A scree plot illustrating the factor loading of the SAQ-F
Table 2 Principal component analysis of the SAQ-F
Item Factor1 Factor2 Factor3 Factor4 Factor5
Physical limitation in middle to strenuous activities
Climbing a hill/stairs 0.603
Gardening, etc 0.745
Walking 100 m or more 0.807
Lifting heavy objects 0.855
Running or jogging 0.800
Strenuous sports 0.603
Physical limitation in slight activities
Dressing 0.789
Walking indoors 0.778
Showering 0.797
Angina pattern and discomfort of treatment
Frequency of symptoms 0.615
Use of tablets 0.723
Troublesome and pills 0.720
Treatment satisfaction
Satisfaction that
everything is done
0.831
Satisfaction with
doctor’s explanation
0.772
Overall satisfaction with
treatment
0.765
Disease perception
Interference with life
enjoyment
0.534
Feelings about
symptom persistence
0.791
Worry about heart
attack/death
0.710
Table 3 The known-group comparison of the SAQ-F
Domain score Asymptomatic
M(SD) n = 30
Symptomatic
M(SD) n = 170
P-value
Physical limitation in
middle to strenuous
activities
34.85 (39.86) 25.71 (35.21) 0.868
Physical limitation in
slight activities
16.22 (91.66) 21.19 (84.62) 0.023
Angina pattern and
discomfort of treatment
8.82 (96.33) 18.84 (63.91) 0.0001
Treatment
satisfaction
20.30 (65.24) 20.46 (60.12) 0.219
Disease perception 24.26 (60.34) 21.19 (35.36) 0.0001
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The study findings revealed that QoL scores in asymp-
tomatic patients in three dimensions of the SAQ-F in-
cluding ‘physical limitation in activities requiring lower
levels of exertion’, ‘angina pattern and discomfort of
treatment’, and ‘disease perception’ were significantly
higher than the symptomatic patients. Seki et al. [20]
also reported significantly higher QoL scores in four out
of five dimensions of the Japanese version of SAQ in
asymptomatic patients—the only exception was related
to the ‘anginal stability’. Nishiyama et al. [32] also re-
ported that asymptomatic patients obtained significantly
higher QoL scores compared to symptomatic patients.
To establish the criterion-related validity of the SAQ-
F, the SAQ and SF-36 QoL questionnaires were adminis-
tered to the participants. The study findings revealed a
significant small-to-moderate levels of correlation be-
tween all the subscales of the two questionnaires with
correlation coefficients ranged from 0.17 to 0.69. Previ-
ous studies also reported the same findings [20–22].
The study findings also revealed that the SAQ-F had
an acceptable internal consistency. Coronbach’s alpha
for different subscales of the SAQ-F ranged between
0.60 and 0.86. Two subscales including ‘angina pattern
and discomfort of treatment’ and ‘disease perception’
had a Coronbach’s alpha coefficient less than 0.70. This
may be attributed to the small number of items in these
two subscales. Waltz et al. [33] noted that the number of
items of a measure directly contributed to the magni-
tude of its Coronbach’s alpha coefficient. The smallest
Coronbach’s alpha coefficient in this study was related to
the ‘angina pattern and discomfort of treatment’ subscale
reported as 0.60. Garratt et al. [21] assessed validity and
reliability of the English version of the SAQ in a sample
of 655 patients with CVD and reported Coronbach’s
alpha coefficients of 0.83–0.92. Coronbach’s alpha coeffi-
cients in a study conducted by Seki et al. [20] were be-
tween 0.51 and 0.96 with 331 patients who suffered
from CVD. Pettersen et al. [22] also evaluated validity
and reliability of the Norwegian SAQ and reported Cor-
onbach’s alpha coefficients between 0.70 and 0.92 with
885 patients who suffered from prior myocardial
infarction.
In this study, reliability of SAQ-F was evaluated by
using the test-retest method. Accordingly, the SAQ-F
was assessed to the study participants twice—with a
two-week interval. The lowest ICC coefficients were re-
lated to the ‘angina pattern and discomfort of treatment’
subscales, respectively. This finding could be attributed
to the high recurrence rate of angina episodes as well as
to the fact that the study sample was consisted of both
hospitalized patients and patients referred to outpatient
care settings. Compared to the original version, the Farsi
version had better results with regard to the domains.
Garratt et al. [21] also reported an acceptable range of
stability between 0.63 and 0.81 for the UK version of the
SAQ [21]. However, Pettersen et al. [22] reported ICC
values between 0.29 and 0.84. Seki et al. [20] in their
study found ICC values between 0.41 and 0.79 that were
below the recommended values (ICC < .80).
Conclusions
The results of this study showed that the SAQ-F had ac-
ceptable psychometric properties. This questionnaire
can be used to measure healthcare outcomes in different
clinical settings and research centres across the world.
The SAQ-F is easy to understand and respond and takes
Table 4 The correlation between the SAQ-F and SF-36
Variable Physical limitation in middle
to strenuous activities
Physical limitation
in slight activities
Angina pattern and
discomfort of treatment
Treatment satisfaction Disease perception
Physical function 0.520** 0.691** 0.379** 0.174** 0.359**
Role physical 0.245** 0.361* 0.328** 0.208** 0.206**
Bodily pain 0.374** 0.415** 0.393** 0.241** 0.516**
General health 0.172* 0.415** 0.391** 0.240** 0.405**
Vitality 0.185** 0.338** 0.361** 0.220** 0.350**
Social function 0.351** 0.353** 0.381** 0.248** 0.395**
Role emotional 0.240** 0.318** 0.335** 0.191** 0.260**
Mental health 0.188* 0.269** 0.241** 0.220** 0.250**
**Correlation is significant at the 0.01 level
*Correlation is significant at the 0.05 level
Table 5 Reliability of the SAQ-F
Domain score Item number ICC P-value
Physical limitation in middle
to strenuous activities
6 0.869 0.91 0.001
Physical limitation in slight
activities
3 0.778 0.97 0.001
Angina pattern and
discomfort of treatment
3 0.602 0.79 0.001
Treatment satisfaction 3 0.740 0.90 0.001
Disease perception 3 0.661 0.91 0.001
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less than 10 min to be completed. It is noteworthy that
the SAQ-F is used for both measuring health-related
QoL and assessing the effects of different medical and
nursing interventions on patients’ QoL.
Limitations of study
Non-random sampling restricts the generalizability of
the study findings. Consequently, multi-centre or multi-
state studies with larger sample sizes are recommended.
Moreover, since we evaluated only the validity and the
reliability of the SAQ-F, more studies for assessing the
responsiveness of the SAQ are also recommended. Fi-
nally, further development of culturally appropriate QoL
questionnaires using qualitative studies is another poten-
tial area of study.
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